What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era?
Author
Edmond, MarkNenclares, Pablo
Harrington, Kevin
Ap Dafydd, Derfel
Bagwan, Izhar
Begg, Donna
Lingley, Ken
Patterson, Gillian
Payne, Miranda
Steven, Neil
Turnbull, Nancy
Yip, Kent
Silva, Priyamal
Kerawala, Cyrus
Paleri, Vinidh
King, Emma
Publication date
2021-08-28Subject
Oncology
Metadata
Show full item recordAbstract
Introduction: The advent of immunotherapy has impacted both the management and, to a lesser extent, the outcomes for patients with head and neck mucosal melanoma. As a consequence, one might expect that the role of the surgeon would be limited to the diagnostic work-up and that systemic therapies would be the mainstay of treatment. Methods and results: Here, we present the surgical aspects of the recently published United Kingdom Head and Neck Mucosal Melanoma Guideline to highlight the continued role of surgeons in the management of this disease. We highlight key areas where surgeons remain the lead clinician and reinforce the multidisciplinary requirement for exemplary patient care. Conclusions: Despite the advent of immunotherapy, surgeons continue to have a key role to play in this disease. When indicated, it is essential that appropriate surgery is offered by a suitably experienced team.Citation
Edmond M, Nenclares P, Harrington K, Ap Dafydd D, Bagwan I, Begg D, Lingley K, Patterson G, Payne M, Steven N, Turnbull N, Yip K, Silva P, Kerawala C, Paleri V, King E. What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era? Head Neck. 2021 Nov;43(11):3498-3503. doi: 10.1002/hed.26849. Epub 2021 Aug 28Type
ArticleOther
Additional Links
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0347PMID
34453460Journal
Head & NeckPublisher
John Wiley & Sonsae974a485f413a2113503eed53cd6c53
10.1002/hed.26849